This article explores lab data integrity violation trends, as well as a sampling of the latest technologies that can help avoid them.
Amber Lowry
Advertisement
Amber Lowry is an associate editor at UBM plc.
Articles by Amber Lowry
This article explores some of the challenges, services, and technologies that go into ensuring that vaccines are properly temperature controlled and maintain product integrity for delivery to patients.
Advertisement
Latest Updated Articles
Cold Chain: Delivering Vaccines to PatientsPublished: November 15th 2017 | Updated:
Maintaining Lab Data IntegrityPublished: February 1st 2018 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
4
Selecting the Right Drug Delivery Formulations to Enhance Patient-Centric Care
5
